| Symbol |
Name |
|
ACBD3
|
acyl-CoA binding domain containing 3
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKR1A1
|
aldo-keto reductase family 1, member A1 (aldehyde reductase)
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
AR
|
androgen receptor
|
|
ATG9B
|
autophagy related 9B
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C1QTNF7
|
C1q and tumor necrosis factor related protein 7
|
|
C1RL
|
complement component 1, r subcomponent-like
|
|
C1S
|
complement component 1, s subcomponent
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C3AR1
|
complement component 3a receptor 1
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C4BPB
|
complement component 4 binding protein, beta
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C6
|
complement component 6
|
|
C7
|
complement component 7
|
|
C8B
|
complement component 8, beta polypeptide
|
|
C9
|
complement component 9
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CD28
|
CD28 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD93
|
CD93 molecule
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFD
|
complement factor D (adipsin)
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFHR5
|
complement factor H-related 5
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLU
|
clusterin
|
|
COMT
|
catechol-O-methyltransferase
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
DHFR
|
dihydrofolate reductase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DRD5
|
dopamine receptor D5
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGCS1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)
|
|
HMGCS2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)
|
|
HP
|
haptoglobin
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL16
|
interleukin 16
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
LEP
|
leptin
|
|
LIPC
|
lipase, hepatic
|
|
LPL
|
lipoprotein lipase
|
|
LTA
|
lymphotoxin alpha
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
OCA2
|
oculocutaneous albinism II
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDSS1
|
prenyl (decaprenyl) diphosphate synthase, subunit 1
|
|
PGR
|
progesterone receptor
|
|
POMC
|
proopiomelanocortin
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial)
|
|
SIRT1
|
sirtuin 1
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STARD3NL
|
STARD3 N-terminal like
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF5
|
TNF receptor-associated factor 5
|
|
TSPO2
|
translocator protein 2
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
